Efficacy and Safety of iGlarLixi vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin-A Systemic Literature Review and Network Meta-analysis

被引：0
|
作者：
Home, Philip
Lauand, Felipe
Djaballah, Khier
Bourhis, Francois
Li, Xuan
Hafidh, Khadija
Mehta, Roopa
Faraoun, Khadra
Anaforoglu, Inan
Pourrahmat, Mir-Masoud
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1880-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1880-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of combination of semaglutide and basal insulin in patients with of type 2 diabetes mellitus: A systematic review and meta-analysis
    Chen, Binbin
    Tao, Lanqiu
    Tian, Min
    Ji, Zhaohua
    CLINICAL NUTRITION ESPEN, 2025, 66 : 564 - 572
  • [22] Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
    Barrie Chubb
    Palvi Gupta
    Jatin Gupta
    Solomon Nuhoho
    Klaus Kallenbach
    Michelle Orme
    Diabetes Therapy, 2021, 12 : 1325 - 1339
  • [23] Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
    Chubb, Barrie
    Gupta, Palvi
    Gupta, Jatin
    Nuhoho, Solomon
    Kallenbach, Klaus
    Orme, Michelle
    DIABETES THERAPY, 2021, 12 (05) : 1325 - 1339
  • [24] Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
    Ayesh, Hazem
    Suhail, Sajida
    Ayesh, Suhail
    Niswender, Kevin
    BIOMEDICINES, 2024, 12 (09)
  • [25] Tolerability and Efficacy of Ipragliflozin in The Management of Inadequately Controlled Type 2 Diabetes mellitus: A Systematic Review and Meta-analysis
    Elgebaly, Ahmed
    Abdelazeim, Nesrine
    Abdelazeim, Bassant
    El Ashal, Gehad
    Mattar, Omar
    Namous, Lubaba
    Nasreldin, Noha
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (01) : 56 - 74
  • [26] Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Wang, C.
    Mamza, J.
    Idris, I.
    DIABETIC MEDICINE, 2015, 32 (05) : 585 - 594
  • [27] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
    Bajaj, H.
    Isendahl, J.
    Gowda, A.
    Stachlewska, K.
    Rosenstock, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
  • [28] Safety and Efficacy of Remogliflozin in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Tewari, Jay
    Qidwai, Khalid Ahmad
    Rana, Anadika
    Tewari, Ajoy
    Tewari, Vineeta
    Maheshwari, Anuj
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [29] Efficacy and Safety of Basal Analog Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ting Hong
    Jing Lu
    Pengzi Zhang
    Zhou Zhang
    Qianyue Xu
    Yunguang Li
    Nan Cui
    Ambar Grijalva
    Erin M. Murray
    Michael A. del Aguila
    Yan Bi
    Diabetes Therapy, 2019, 10 : 1051 - 1066
  • [30] Efficacy and Safety of Basal Analog Regimens in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Hong, Ting
    Lu, Jing
    Zhang, Pengzi
    Zhang, Zhou
    Xu, Qianyue
    Li, Yunguang
    Cui, Nan
    Grijalva, Ambar
    Murray, Erin M.
    del Aguila, Michael A.
    Bi, Yan
    DIABETES THERAPY, 2019, 10 (03) : 1051 - 1066
12345